Cancer Biology & Medicine Open Access Editor-in-Chief: Xishan Hao
Home Cancer Biology & Medicine All Issues Volume 23 Issue 8
Volume 23 Issue 8, August 2026
Cover
Cover
PP. 1051-1203
|
9 articles
Previous Issue
|
Next Issue
PERSPECTIVE
Perspective | Open Access
Less is more: patients with cervical cancer benefit from de-escalated chemotherapy plus immuno-targeted therapies
Bohao Zheng, Dian Fan, Shengtao Zhou
Published: 22 June 2026
2026, 23(8): 1051-1056
REVIEW
Review | Open Access
Harnessing the microbiome: a new frontier in lung cancer immunotherapy
Kexin Feng, Jun Wang, Shuai Wang, [...], Zewen Sun, Mantang Qiu, Zuli Zhou, Yun Li, Kezhong Chen << Fewer
Published: 20 July 2026
2026, 23(8): 1057-1086
Review | Open Access
Tumor microenvironment-driven natural killer cell diversity: mechanisms and therapeutic opportunities
Yue Duan, Mingzhen Zhou, Xingxian Guo, [...], Tianyu Cao, Yuanyuan Lu, Xiaodi Zhao << Fewer
Published: 25 April 2026
2026, 23(8): 1087-1107
Review | Open Access
Surgery-centered integrated strategies for personalized hepatocellular carcinoma care
Yuhan Cui, Zuchao Du, Jiahao Xu, [...], Lihui Gu, Jiaqi Du, Mingda Wang, Tian Yang << Fewer
Published: 30 March 2026
2026, 23(8): 1108-1127
ORIGINAL ARTICLE
Original Article | Open Access
Exosomal EPHA2 transfers metastatic potential by stabilizing TGF-βRI and activating the TGF-β/SMAD3 signaling pathway in breast cancer
Liming Liu, Yichu Zhang, Xiaoxue Li, [...], Yueni Mo, Lanlan Song, Yidi Jia, Luoming Zhang, Wei Zhou, He Zhang, Hui Guo, Zhiyong Wang, Yanfen Cui, Fei Zhang, Ruifang Niu << Fewer
Published: 23 February 2026
2026, 23(8): 1128-1155
Original Article | Open Access
Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer: a prospective, multicenter, non-interventional study (FLOURISH)
Lisha Shen, Dongqing Lv, Ke-Jing Tang, [...], Jun Zhao, Dan Zhu, Yanqiu Zhao, Ke Wang, Yan Wang, Zhigang Cai, Ligang Xing, Ke Xie, Jiuwei Cui, Lin Mu, Chao Cao, Liren Ding, Peifeng Chen, Jun Liang, Yongmin Ding, Liqin Lu, Jiliang Zhang, Xinmin Yu, Li Chen, Jing Zheng, Jianya Zhou, Jianying Zhou << Fewer
Published: 21 May 2026
2026, 23(8): 1156-1166
Original Article | Open Access
Myeloid cell reprogramming combined with zoledronic acid effectively suppresses bone metastasis
Yuting Luo, Yiran Cai, Zizheng Jiang, [...], Ke Zheng, Shiji Ren, Lixia Yu, Baorui Liu, Tao Shi, Jia Wei << Fewer
Published: 27 July 2026
2026, 23(8): 1167-1192
LETTER
Letter | Open Access
Dietary restriction during active cancer therapy is associated with improved treatment response: a systematic review and meta-analysis
Kajal Agrawal, Dominic Shao Yong Goh, Ee Chern Ng, [...], Shyn Yi Tan, Carlos Cifuentes-González, Jason Xing Kang, William K. K. Wu, Rashid N. S. Lui, Rupesh Agrawal, Yusuf Ali, Sunny H. Wong << Fewer
Published: 13 July 2026
2026, 23(8): 1193-1197
Letter | Open Access
Unveiling molecular incomplete response (mIR) via ultra-deep NGS: a novel concept contrasting pathologic complete response (pCR) in occult lymph node micrometastases of non-small cell lung cancer
Meng Lu, Ran Zhang, Haidi Xu, [...], Bingsheng Sun, Peng Chen, Xuan Gao, Meiming Zhong, Jian You << Fewer
Published: 12 June 2026
2026, 23(8): 1198-1203